We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Review · April 21, 2021

Immune Checkpoint Inhibitor Therapy in the Perioperative Setting for Renal Cancer

Current opinion in urology


Additional Info

Current opinion in urology
Perioperative Therapy in Renal Cancer in the Era of Immune Checkpoint Inhibitor Therapy
Curr Opin Urol 2021 May 01;31(3)262-269, T Kuusk, Y Abu-Ghanem, F Mumtaz, T Powles, A Bex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.

Further Reading